Log in to save to my catalogue

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b153950d8954406096bbc73c512bfa18

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

About this item

Full title

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

Publisher

Cheshire: Springer Healthcare

Journal title

Neurology and Therapy, 2019-12, Vol.8 (2), p.241-250

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to relapse or disease progression. In some cases, severe MS diseas...

Alternative Titles

Full title

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b153950d8954406096bbc73c512bfa18

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b153950d8954406096bbc73c512bfa18

Other Identifiers

ISSN

2193-8253

E-ISSN

2193-6536

DOI

10.1007/s40120-019-00160-9

How to access this item